2006
DOI: 10.1038/ncb1438
|View full text |Cite|
|
Sign up to set email alerts
|

The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl–Crk pathway

Abstract: Recent evidence supports a role for EphB receptor tyrosine kinases as tumour suppressors in colorectal and prostate cancer. However, it is unclear how these receptors inhibit cancer cell tumorigenicity - an activity that is highly unusual for a family of receptor tyrosine kinases. Here, we report that the EphB4 receptor can behave as a tumour suppressor in a mouse xenograft model of breast cancer when stimulated by its ligand, ephrin-B2. In breast cancer cells, EphB4 activates an antioncogenic pathway involvin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

24
287
1

Year Published

2007
2007
2012
2012

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 268 publications
(315 citation statements)
references
References 49 publications
24
287
1
Order By: Relevance
“…Previous studies also demonstrated that activation of EphB receptors by ephrin-B1 or ephrin-B2 results in the activation of E-cadherin adhesion (41,42). These studies are consistent with our observations here that the loss of ephrin-A5 leads to the disruption of N-cadherin-␤-catenin interactions, resulting in a loss of cell-cell adhesion.…”
Section: Regulation Of N-cadherin and ␤-Cateninsupporting
confidence: 82%
“…Previous studies also demonstrated that activation of EphB receptors by ephrin-B1 or ephrin-B2 results in the activation of E-cadherin adhesion (41,42). These studies are consistent with our observations here that the loss of ephrin-A5 leads to the disruption of N-cadherin-␤-catenin interactions, resulting in a loss of cell-cell adhesion.…”
Section: Regulation Of N-cadherin and ␤-Cateninsupporting
confidence: 82%
“…Although the mechanism by which BCR-Abl drives leukemiagenesis is well understood, there is little information on the effects of Abl proteins on the development or progression of solid tumors (Singer et al, 2004;Van Diest et al, 2004;Nahta et al, 2005;Nagano et al, 2006;Noren et al, 2006;Vantaggiato et al, 2006). Here, we identify a novel mechanism by which c-Abl promotes breast cancer cell growth and invasion by upregulating ERa expression (Figure 6).…”
Section: Discussionmentioning
confidence: 88%
“…More recently, ephrin/Eph cues have been shown to be pro-apoptotic in other cellular contexts (Figueroa et al 2006;Noren et al 2006), but also in some cases they seem to act as prosurvival factors, at least in adult mouse neural stem cells (Furne et al 2009;Ricard et al 2006). In the latter case, it has been proposed that EphA4 may act as a dependence receptor that would promote cell death in the absence of ephrin ligands, following caspase cleavage processes similar to the ones described for DCC and Unc5 (Furne et al 2009).…”
Section: Ephrinsmentioning
confidence: 99%